534 related articles for article (PubMed ID: 29411301)
1. Emerging Biomarkers in Cutaneous Melanoma.
Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
[TBL] [Abstract][Full Text] [Related]
2. Circulating biomarkers in malignant melanoma.
Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
[TBL] [Abstract][Full Text] [Related]
3. Current status of diagnostic and prognostic markers in melanoma.
Levine D; Fisher DE
Methods Mol Biol; 2014; 1102():177-97. PubMed ID: 24258980
[TBL] [Abstract][Full Text] [Related]
4. Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
Hyams DM; Cook RW; Buzaid AC
J Surg Oncol; 2019 Jan; 119(2):175-186. PubMed ID: 30548543
[TBL] [Abstract][Full Text] [Related]
5. New prognostic factors of cutaneous melanoma: a review of the literature.
Li N; Mangini J; Bhawan J
J Cutan Pathol; 2002 Jul; 29(6):324-40. PubMed ID: 12135463
[No Abstract] [Full Text] [Related]
6. Current Molecular Markers of Melanoma and Treatment Targets.
Yang K; Oak ASW; Slominski RM; Brożyna AA; Slominski AT
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429485
[TBL] [Abstract][Full Text] [Related]
7. Molecular markers of circulating melanoma cells.
Medic S; Pearce RL; Heenan PJ; Ziman M
Pigment Cell Res; 2007 Apr; 20(2):80-91. PubMed ID: 17371435
[TBL] [Abstract][Full Text] [Related]
8. Screening and identification of potential prognostic biomarkers in metastatic skin cutaneous melanoma by bioinformatics analysis.
Sheng Z; Han W; Huang B; Shen G
J Cell Mol Med; 2020 Oct; 24(19):11613-11618. PubMed ID: 32869947
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
10. Monitoring Melanoma Using Circulating Free DNA.
Diefenbach RJ; Lee JH; Rizos H
Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
12. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
13. New developments in biomarkers for melanoma.
Griewank KG; Ugurel S; Schadendorf D; Paschen A
Curr Opin Oncol; 2013 Mar; 25(2):145-51. PubMed ID: 23334230
[TBL] [Abstract][Full Text] [Related]
14. Impact of genomics on the surgical management of melanoma.
Ferguson PM; Long GV; Scolyer RA; Thompson JF
Br J Surg; 2018 Jan; 105(2):e31-e47. PubMed ID: 29341162
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
16. [Melanoma-stroma interactions and melanoma progression].
Ruiter DJ; Herlyn M
J Dtsch Dermatol Ges; 2003 Oct; 1(10):773-6. PubMed ID: 16281812
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic, Prognostic and Predictive Immunohistochemistry in Malignant Melanoma of the Skin.
Luca R
Klin Onkol; 2018; 31(2):152-155. PubMed ID: 29708359
[No Abstract] [Full Text] [Related]
18. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
Bougnoux AC; Solassol J
Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
Huang SK; Hoon DS
Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in Melanoma: Lessons from Translational Medicine.
Buchbinder EI; Flaherty KT
Trends Cancer; 2016 Jun; 2(6):305-312. PubMed ID: 28741528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
